Composition
- Active ingredients
- OXYMORPHONE HYDROCHLORIDE 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- OXYMORPHONE HYDROCHLORIDE 40MG · Tablet, extended releaseNDA201655-007 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 20MG · Tablet, extended releaseNDA201655-005 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 10MG · Tablet, extended releaseNDA201655-003 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 5MG · Tablet, extended releaseNDA201655-001 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 30MG · Tablet, extended releaseNDA201655-006 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 15MG · Tablet, extended releaseNDA201655-004 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 7.5MG · Tablet, extended releaseNDA201655-002 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA021610-007 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA021610-005 · Discontinued
- OXYMORPHONE HYDROCHLORIDE 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended release
At a glance
- Brand name
- Opana ER
- Active substance
- oxymorphone hydrochloride
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Endo Operations
- Status
- Discontinued
- FDA approval
- 22 Jun 2006
- Application
- NDA021610-001